Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
| Image |  |
|---|---|
| Description | scientific article published on 07 March 2017 |
| Author/s |
author: Mohamed El-Shinawi Mona Mostafa Mohamed Martin Götte |
| Publication date | March 7, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |